Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03330041 · ClinicalTrials.gov registry record · NA
Suturing Distance From the Wound Edge, 2 mm vs 5 mm
A NA study of Cutaneous Sutures and Scar Cosmesis, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03330041: Completed NA study of Cutaneous Sutures and Scar Cosmesis, sponsored by University of California, Davis.
NCT03330041 is a NA study of Cutaneous Sutures and Scar Cosmesis that has completed, run by University of California, Davis. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03330041, a NA study of Cutaneous Sutures and Scar Cosmesis, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to investigate whether the spacing of the interrupted cutaneous sutures affects surgical wound cosmesis on the face and neck. In other words, the investigators would like to determine which of the following yields a more cosmetically appealing scar: many closely approximated sutures or fewer, more widely spaced sutures. The investigators wish to compare the effects of two versus five millimeter spacing between sutures.
Primary Outcome
Scale name: Patient Observer Scar Assessment Score. Scale measures six parameters of scars, each using a 10-point scoring system (the six categories are summed to achieve the POSAS score - totals range from 6 to 60), with 1 representing normal skin \& 10 representing the most severe scar imaginable.
Conditions Studied
Interventions
- DEVICE Fast absorbing gut suture
Study Locations (1)
California
- University of California, Davis, Department of Dermatology - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-10-03 |
| Est. Completion | 2018-08-09 |
| Phase | NA |
What the finished NCT03330041 record still lists
NCT03330041 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cutaneous Sutures and Scar Cosmesis appearing as the primary indexed condition, and to 1 intervention - of which Fast absorbing gut suture is the first listed.
NCT03330041 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03330041 about?
NCT03330041 is a clinical study titled "Suturing Distance From the Wound Edge, 2 mm vs 5 mm". This study aims to investigate whether the spacing of the interrupted cutaneous sutures affects surgical wound cosmesis on the face and neck. In other words, the investigators would like to determine which of the following yields a more cosmetically appealing scar: many closely approximated sutures ...
What is the current status of trial NCT03330041?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-10-03. Estimated completion is 2018-08-09.
What conditions does trial NCT03330041 study?
This clinical trial studies the following conditions: Cutaneous Sutures and Scar Cosmesis.
What interventions are being tested in trial NCT03330041?
The interventions under investigation include: Fast absorbing gut suture (DEVICE).
Who is sponsoring clinical trial NCT03330041?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03330041 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03330041's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI